Roy A. Whitfield - Dec 31, 2024 Form 5 Insider Report for NEKTAR THERAPEUTICS (NKTR)

Role
Director
Signature
Mark A. Wilson, Attorney-in-Fact
Stock symbol
NKTR
Transactions as of
Dec 31, 2024
Transactions value $
$0
Form type
5
Date filed
1/17/2025, 08:39 PM
Previous filing
Sep 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests in equal monthly installments over the one-year period beginning on September 18, 2024.